New Austrian mutation in BRCA1 gene detected in three unrelated HBOC families

Surgery-first versus neoadjuvant chemotherapy in stage I (cT1c) triple-negative breast cancer: A critical reappraisal.

Breast (Edinburgh, Scotland)·2026

Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge.

Allergy·2026

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0).

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Dissecting the Sensitization Profiles in Parvalbumins From 12 Freshwater Fish Species to Improve Diagnosis of Fish Allergy.

Journal of investigational allergology & clinical immunology·2025

Cosensitization to the 3 Nonhomologous Major Cashew Allergens Ana o 1, Ana o 2, and Ana o 3 Is Caused by IgE Cross-reactivity.

Journal of investigational allergology & clinical immunology·2022

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring.

ESMO open·2021

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Reassessment of the Early Cretaceous North American "troodontid" Geminiraptor suarezarum as a therizinosaurian and mosaic evolution of coelurosaurian maxillae.

PloS one·2026

Correction: Cranial Osteology of Fona herzogae (Dinosauria: Thescelosaurinae) from the Mussentuchit Member of the Cedar Mountain Formation.

PloS one·2026

The construction of masculinity in Selk'nam culture. A psychoanalytic understanding of the initiation ceremony.

The International journal of psycho-analysis·2026

New low-genus desingularizations of three Clifford tori and related characterizations.

Geometriae dedicata·2026

T1-Weighted MRI of the proximal humerus: Toward a non-ionizing approach to forensic age estimation in a French cohort.

International journal of legal medicine·2026

Ancient DNA reveals early use of melons in China's Song dynasty.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Videos

New Austrian mutation in BRCA1 gene detected in three unrelated HBOC families

Related Concept Videos

Surgery-first versus neoadjuvant chemotherapy in stage I (cT1c) triple-negative breast cancer: A critical reappraisal.

Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge.

ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0).

Dissecting the Sensitization Profiles in Parvalbumins From 12 Freshwater Fish Species to Improve Diagnosis of Fish Allergy.

Cosensitization to the 3 Nonhomologous Major Cashew Allergens Ana o 1, Ana o 2, and Ana o 3 Is Caused by IgE Cross-reactivity.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Reassessment of the Early Cretaceous North American "troodontid" Geminiraptor suarezarum as a therizinosaurian and mosaic evolution of coelurosaurian maxillae.

Correction: Cranial Osteology of Fona herzogae (Dinosauria: Thescelosaurinae) from the Mussentuchit Member of the Cedar Mountain Formation.

The construction of masculinity in Selk'nam culture. A psychoanalytic understanding of the initiation ceremony.

New low-genus desingularizations of three Clifford tori and related characterizations.

T1-Weighted MRI of the proximal humerus: Toward a non-ionizing approach to forensic age estimation in a French cohort.

Ancient DNA reveals early use of melons in China's Song dynasty.

Related Experiment Videos

New Austrian mutation in BRCA1 gene detected in three unrelated HBOC families

Related Concept Videos

Related Articles